Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Oxford Investment Consultants (OIC) was established in 2015 by George Robinson and Ross Hyett. The firm is headquartered in Oxford, UK, and specializes in early-stage investments in technology and biotech sectors. OIC primarily targets companies that are spinouts from Oxford University and other prestigious UK research institutions, leveraging the region's rich academic resources.
As of now, OIC manages a diverse portfolio that includes several notable companies, reflecting its commitment to addressing significant global challenges. The firm has built a team comprising several partners and associates, enhancing its capacity to identify and support promising startups. OIC's focus on transformative companies positions it as a key player in the UK investment landscape.
OIC invests across various stages, from Seed to Series C funding rounds, emphasizing early-stage technology and biotech companies. The firm’s investment strategy is centered on transformative companies that tackle significant global challenges, particularly in biotechnology, healthcare, and technology sectors. OIC seeks to partner with startups that demonstrate innovative solutions and strong potential for growth.
Investment checks typically range from early seed funding to larger Series C rounds, allowing OIC to support companies as they scale. The firm is particularly interested in startups that emerge from leading UK research institutions, which often possess unique intellectual property and a strong foundation for development.
OIC's portfolio includes several notable companies that exemplify its investment focus:
These companies reflect OIC's commitment to investing in innovative solutions that address critical health and technology challenges.
George Robinson: Founding Partner with extensive experience in venture capital and a background in technology investments.
Ross Hyett: Founding Partner who has a strong focus on biotech investments and a history of supporting early-stage companies.
Christopher Hall: Partner with expertise in healthcare investments and a track record of successful exits.
James Mallinson: Partner who specializes in technology investments and has a background in engineering.
Tania Wilson: Principal and CFO, responsible for financial strategy and operations within the firm.
William Middleton: Principal with a focus on identifying promising startups in the biotech sector.
Alexander Chamberlain: Senior Associate who supports deal sourcing and due diligence processes.
Hector Edwards: Associate involved in portfolio management and operational support for startups.
To pitch to OIC, founders should send their proposals via email to applications@oxfordinvestmentconsultants.com. It is important to include a comprehensive deck that outlines the business model, market opportunity, and team qualifications. Response times may vary, but founders should expect a thorough review process.
In recent months, OIC has continued to expand its portfolio, focusing on innovative companies in the biotech and technology sectors. Notable investments include Biofidelity and Caristo Diagnostics, both of which are making strides in their respective fields.
OIC remains committed to supporting early-stage companies that align with its investment thesis, particularly those addressing significant global challenges. The firm is actively seeking new opportunities to invest in transformative technologies.
What are OIC's investment criteria?
OIC focuses on early-stage technology and biotech companies, particularly those that are spinouts from leading UK research institutions. They look for transformative solutions that address significant global challenges.
How can I apply or pitch to OIC?
Founders can pitch their ideas by sending an email to applications@oxfordinvestmentconsultants.com. It is advisable to include a detailed business plan and any relevant data that supports the startup's potential.
What makes OIC different from other investors?
OIC's unique focus on spinouts from prestigious research institutions in the UK sets it apart. This allows them to access innovative technologies and ideas that may not be available to other investors.
What is OIC's geographic scope?
OIC primarily invests in companies based in the United Kingdom, particularly those emerging from Oxford University and other leading research institutions.
What is OIC's post-investment involvement like?
OIC typically engages with portfolio companies through board involvement and operational support, helping them navigate growth challenges and scale effectively.
What is the typical check size for investments?
OIC invests across various stages, with check sizes varying from Seed to Series C funding rounds, allowing flexibility based on the startup's needs.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.